New Antivirals and WinRivir Progress

Merck describes long‑acting influenza antiviral trials and Minervir's progress in pulmonary hypertension.

Play episode from 40:30

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!